Lyons Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-4,037
Closed -$784K 15
2018
Q4
$784K Buy
4,037
+111
+3% +$21.7K 2.56% 12
2018
Q3
$813K Sell
3,926
-848
-18% -$167K 1.61% 25
2018
Q2
$881K Sell
4,774
-1,086
-19% -$192K 1.26% 14
2018
Q1
$999K Buy
+5,860
New +$1.08M 1.52% 10
2016
Q1
Sell
-1,261
Closed -$205K 63
2015
Q4
$205K Buy
+1,261
New +$198K 0.26% 50
2013
Q3
Sell
-3,643
Closed -$359K 78
2013
Q2
$359K Buy
+3,643
New +$378K 0.36% 29

Other funds holding AMGN

Lyons Wealth Management's AMGN Position: Q1 2019 in Review

Lyons Wealth Management sold out of Amgen (AMGN) in Q1 2019, closing a stake of 4,037 shares — an estimated $784K sold.

Lyons Wealth Management first reported a position in AMGN in Q2 2013 and held it in 6 quarters. The position peaked at $999K in Q1 2018. 1,887 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Lyons Wealth Management reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Lyons Wealth Management sold 4,037 Amgen shares in Q1 2019, an estimated $784K.
  • Lyons Wealth Management first reported a position in Amgen in Q2 2013 and held it in 6 quarters.
  • Lyons Wealth Management's Amgen position peaked at $999K in Q1 2018.
  • 1,887 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Lyons Wealth Management's 13F filing for Q1 2019, filed 14 May 2019.